Cedrik Michael Britten
Immatics Biotechnologies (Germany) · 283 works · 7,846 citations · h-index 43
Top works
- Exploiting the Mutanome for Tumor Vaccination
- Cancer classification using the Immunoscore: a worldwide task force
- “MIATA”—Minimal Information about T Cell Assays
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- Response definition criteria for ELISPOT assays revisited
- Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
- Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
- Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
- Defining the critical hurdles in cancer immunotherapy
- The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8+ T lymphocytes in IFN-γ ELISPOT assays
- Phase II Trial of a Toll-Like Receptor 9–Activating Oligonucleotide in Patients With Metastatic Melanoma
- Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- Harmonization of Immune Biomarker Assays for Clinical Studies
- Hierarchical Modeling for Rare Event Detection and Cell Subset Alignment across Flow Cytometry Samples
- Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
- Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
- T Cell Assays and MIATA: The Essential Minimum for Maximum Impact